Spelman L, Rosen R, Knudsen KM, Zibert JR, Freeman M. Ingenol mebutate 0.05% gel under occlusion is efficacious in treating superficial basal cell carcinoma. B J Dermatol. 2014;171(Suppl. 4):58–9.
Compare quality appraisals for each clinical question
- What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?